Frankfurt - Delayed Quote EUR

Regulus Therapeutics Inc. (7RG0.F)

6.85
-0.15
(-2.14%)
At close: May 30 at 8:01:50 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
51,752
50,040
31,109
28,239
27,816
Operating Income
-51,752
-50,040
-31,109
-28,239
-27,816
Net Non Operating Interest Income Expense
4,230
3,683
1,073
-83
9
Pretax Income
-47,522
-46,357
-30,036
-28,322
-27,807
Tax Provision
--
1
1
1
1
Net Income Common Stockholders
-47,523
-46,358
-30,037
-28,323
-27,808
Diluted NI Available to Com Stockholders
-47,523
-46,358
-30,037
-28,323
-27,808
Basic EPS
-0.68
--
-1.58
-1.86
-3.20
Diluted EPS
-0.68
--
-1.58
-1.86
-3.20
Basic Average Shares
65,702.97
--
18,960.40
15,259.96
8,570.45
Diluted Average Shares
65,702.97
--
18,960.40
15,259.96
8,570.45
Total Operating Income as Reported
-51,752
-50,040
-31,109
-28,239
-27,816
Total Expenses
51,752
50,040
31,109
28,239
27,816
Net Income from Continuing & Discontinued Operation
-47,523
-46,358
-30,037
-28,323
-27,808
Normalized Income
-47,523
-46,358
-30,037
-28,323
-27,808
Interest Income
4,324
3,841
1,677
605
864
Interest Expense
94
158
604
688
855
Net Interest Income
4,230
3,683
1,073
-83
9
EBIT
-47,428
-46,199
-29,432
-27,634
-26,952
EBITDA
-47,077
-45,852
-29,205
-27,512
-26,493
Reconciled Depreciation
351
347
227
122
459
Net Income from Continuing Operation Net Minority Interest
-47,523
-46,358
-30,037
-28,323
-27,808
Normalized EBITDA
-47,077
-45,852
-29,205
-27,512
-26,493
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/21/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1JK.SG Apellis Pharmaceuticals Inc
15.22
+1.18%
 
IM8N.F Insmed Incorporated
60.50
+2.54%
 
49BA.SG BeiGene Ltd
216.00
+0.93%
 
NRSNW NeuroSense Therapeutics Ltd.
0.4840
+42.35%
 
GUTS Fractyl Health, Inc.
1.9000
0.00%
 
RNA Avidity Biosciences, Inc.
30.98
-2.27%
 
NRSN NeuroSense Therapeutics Ltd.
1.5400
+2.67%
 
PALI Palisade Bio, Inc.
0.7420
+7.96%
 
LCTX Lineage Cell Therapeutics, Inc.
0.6647
-3.10%
 
TNYA Tenaya Therapeutics, Inc.
0.4600
+3.51%